Synthetic Biologics, Inc. (NYSEMKT:SYN)

CAPS Rating: 1 out of 5

A development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and fibrotic diseases.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 8/6/2012 9:56:44 PM : Underperform Start Price: $2.00 SYN Score: +6.47

Look out below, this one may accelerate downward

Featured Broker Partners


Advertisement